These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 23507851)

  • 1. DOT corrected fluorescence molecular tomography using targeted contrast agents for small animal tumor imaging.
    Tan Y; Cao Z; Sajja HK; Lipowska M; Wang YA; Yang L; Jiang H
    J Xray Sci Technol; 2013; 21(1):43-52. PubMed ID: 23507851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.
    Yang L; Sajja HK; Cao Z; Qian W; Bender L; Marcus AI; Lipowska M; Wood WC; Wang YA
    Theranostics; 2013; 4(1):106-18. PubMed ID: 24396518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular photoacoustic tomography of breast cancer using receptor targeted magnetic iron oxide nanoparticles as contrast agents.
    Xi L; Grobmyer SR; Zhou G; Qian W; Yang L; Jiang H
    J Biophotonics; 2014 Jun; 7(6):401-9. PubMed ID: 23125139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-targeted nanoparticles for in vivo imaging of breast cancer.
    Yang L; Peng XH; Wang YA; Wang X; Cao Z; Ni C; Karna P; Zhang X; Wood WC; Gao X; Nie S; Mao H
    Clin Cancer Res; 2009 Jul; 15(14):4722-32. PubMed ID: 19584158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Evaluation of a Miniaturized Fluorescence Molecular Tomography (FMT) Endoscope for Breast Cancer Detection Using Targeted Nanoprobes.
    Yang H; Qian W; Yang L; Xie H; Jiang H
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33317217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.
    Christensen A; Juhl K; Persson M; Charabi BW; Mortensen J; Kiss K; Lelkaitis G; Rubek N; von Buchwald C; Kjær A
    Oncotarget; 2017 Feb; 8(9):15407-15419. PubMed ID: 28039488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel tumor targeting drug carrier for optical imaging and therapy.
    Li R; Zheng K; Hu P; Chen Z; Zhou S; Chen J; Yuan C; Chen S; Zheng W; Ma E; Zhang F; Xue J; Chen X; Huang M
    Theranostics; 2014; 4(6):642-59. PubMed ID: 24723985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway.
    Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H
    Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Targeted NIR-II Probe for Image-Guided Brain Tumor Surgery.
    Kurbegovic S; Juhl K; Chen H; Qu C; Ding B; Leth JM; Drzewiecki KT; Kjaer A; Cheng Z
    Bioconjug Chem; 2018 Nov; 29(11):3833-3840. PubMed ID: 30296054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A drug carrier targeting murine uPAR for photodynamic therapy and tumor imaging.
    Zhou X; Zheng K; Li R; Chen Z; Yuan C; Hu P; Chen J; Xue J; Huang M
    Acta Biomater; 2015 Sep; 23():116-126. PubMed ID: 26004218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.
    Gao N; Bozeman EN; Qian W; Wang L; Chen H; Lipowska M; Staley CA; Wang YA; Mao H; Yang L
    Theranostics; 2017; 7(6):1689-1704. PubMed ID: 28529645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer.
    Miller-Kleinhenz J; Guo X; Qian W; Zhou H; Bozeman EN; Zhu L; Ji X; Wang YA; Styblo T; O'Regan R; Mao H; Yang L
    Biomaterials; 2018 Jan; 152():47-62. PubMed ID: 29107218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.
    Lee GY; Qian WP; Wang L; Wang YA; Staley CA; Satpathy M; Nie S; Mao H; Yang L
    ACS Nano; 2013 Mar; 7(3):2078-89. PubMed ID: 23402593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of an (111)In-labeled peptide for the in vivo localization of human cancers expressing the urokinase-type plasminogen activator receptor (uPAR).
    Liu D; Overbey D; Watkinson L; Giblin MF
    Bioconjug Chem; 2009 May; 20(5):888-94. PubMed ID: 19354275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles.
    Yang L; Mao H; Cao Z; Wang YA; Peng X; Wang X; Sajja HK; Wang L; Duan H; Ni C; Staley CA; Wood WC; Gao X; Nie S
    Gastroenterology; 2009 May; 136(5):1514-25.e2. PubMed ID: 19208341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts.
    Kurbegovic S; Juhl K; Sørensen KK; Leth J; Willemoe GL; Christensen A; Adams Y; Jensen AR; von Buchwald C; Skjøth-Rasmussen J; Ploug M; Jensen KJ; Kjaer A
    Theranostics; 2021; 11(15):7159-7174. PubMed ID: 34158842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy.
    Abdalla MO; Karna P; Sajja HK; Mao H; Yates C; Turner T; Aneja R
    J Control Release; 2011 Feb; 149(3):314-22. PubMed ID: 21047537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial glioma xenograft model rapidly reestablishes blood-brain barrier integrity for longitudinal imaging of tumor progression using fluorescence molecular tomography and contrast agents.
    Habimana-Griffin L; Ye D; Carpenter J; Prior J; Sudlow G; Marsala L; Mixdorf M; Rubin J; Chen H; Achilefu S
    J Biomed Opt; 2020 Feb; 25(2):1-13. PubMed ID: 32112540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice.
    Jo M; Takimoto S; Montel V; Gonias SL
    Am J Pathol; 2009 Jul; 175(1):190-200. PubMed ID: 19497996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
    Zhu F; Jia S; Xing G; Gao L; Zhang L; He F
    DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.